Xiaoyan Si

38PUBLICATIONS
37CO-AUTHORS
Central nervous systemMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|May 20, 2026
Efficacy and safety of tocilizumab for neoplastic fever in patients with advanced solid tumors: a multicenter retrospective study.

|Nov 22, 2025
Afatinib for a non-small cell lung cancer patient in hemodialysis: A case report and literature review.

Yu Yan, Xin Zheng, Xue Zhao

|Jun 17, 2025
Safety and Efficacy of the First Subcutaneous ICI, Envafolimab, in the Treatment of Advanced Lung Cancer Patients: A Real-World Study.

Zixuan Dou, Li Wang, Meng Rui

|Mar 12, 2025
Chinese Expert Consensus on the Diagnosis and Treatment of Inflammatory Myofibroblastic Tumor.

Xiaoyan Si, Shafei Wu, Rui'e Feng

|Nov 26, 2024
Clinicopathological Characteristics of Inflammatory Myofibroblastic Tumor: A Single Center Retrospective Cohort Study.

Xiaoyan Si, Shafei Wu, Ruie Feng

|Oct 29, 2024
Characterization of renal injury in non-squamous non-small cell lung cancer patients treated with pemetrexed: A single-center retrospective study.

Yang Wu, Kang Miao, Minjiang Chen

Pageof 7

Frequent Collaborators

28 joint publications

Hanping Wang

15 joint publications

Zhang Xiaotong

11 joint publications

Xiaoxiao Guo

10 joint publications

Jiaxin Zhou